VYNE THERAPEUTICS INC. (YARW) Total liabilities 2016–2025
VYNE THERAPEUTICS INC. (YARW) total liabilities at each fiscal year-end, per SEC filings.
$2.4MFY2025 · since FY2016: $12.5M → $2.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $2.4M | -83.8% |
| FY2024 | $14.8M | +65.6% |
| FY2023 | $8.9M | -4.2% |
| FY2022 | $9.3M | -49.2% |
| FY2021 | $18.4M | -67.3% |
| FY2020 | $56.2M | -11.5% |
| FY2019 | $63.6M | +565.7% |
| FY2018 | $9.6M | -34.5% |
| FY2017 | $14.6M | +16.7% |
| FY2016 | $12.5M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice